Cystic fibrosis affects how the body moves salt and water, often leaving unusually high chloride levels in sweat. Learn how sweat chloride testing works, what a result above 60 mmol/L may indicate, and why clinicians consider it alongside a person’s symptoms and other findings.

Multiple Choice

Which laboratory result is critical in evaluating a patient for cystic fibrosis?

The sweat chloride level is pivotal in the evaluation of a patient for cystic fibrosis because it helps to confirm the diagnosis of this genetic disorder. Cystic fibrosis is caused by mutations in the CFTR gene, which affects the body's ability to regulate salt and water in epithelial cells. As a result, individuals with cystic fibrosis typically have higher concentrations of chloride in their sweat. Testing the sweat chloride level involves stimulating sweat production and measuring the chloride concentration in the collected sweat. A sweat chloride level of greater than 60 millimoles per liter is considered indicative of cystic fibrosis and is a critical diagnostic criterion. Other testing options may be relevant in different clinical scenarios but do not specifically diagnose cystic fibrosis. For instance, the Tensilon challenge is primarily used in diagnosing myasthenia gravis, while an acid-fast sputum test is used to identify tuberculosis. The Elisa test is often used for various immunological assessments and screening for infections but is not specific to cystic fibrosis. Thus, the sweat chloride level remains the key laboratory result in the context of evaluating cystic fibrosis.

Cystic fibrosis can affect the lungs, digestive system, and other organs, yet its effects often begin with a tiny change in how cells move salt and water. One laboratory result helps reveal that change: the sweat chloride level. Because people with cystic fibrosis tend to have unusually high chloride concentrations in their sweat, measuring it can provide strong evidence of the condition.

That simple-sounding test has a bigger story behind it. It connects genetics, cell biology, and everyday symptoms—and it shows how a small sample of sweat can offer important clues about a complex disease.

Why salt matters so much

Cystic fibrosis is an inherited condition caused by changes in the CFTR gene. This gene carries instructions for making a protein that helps regulate the movement of chloride and other particles across cell surfaces. Chloride is part of common salt, and its movement helps control how water travels through the body’s tissues.

When CFTR doesn’t work as it should, that balance shifts. In the lungs, mucus can become thick and sticky, making it harder to clear germs and debris. This can lead to repeated lung infections and ongoing breathing problems. In the pancreas, thick secretions may block the release of digestive enzymes, so the body has trouble absorbing nutrients. The effects vary from person to person, but the underlying issue is the same: disrupted movement of salt and water.

Sweat offers a useful window into this process. In healthy sweat glands, chloride is taken back into the body as sweat moves along the gland’s duct. In cystic fibrosis, this reabsorption is impaired. More chloride remains in the sweat, which is why its concentration can be elevated.

A closer look at the sweat chloride test

The sweat chloride test measures the amount of chloride in a small sample of sweat. A health professional first applies a medication called pilocarpine to a small area of skin, often on the forearm. A mild electrical current helps the medication stimulate the sweat gland. The process is called iontophoresis; it may sound technical, but the current is gentle and isn’t meant to cause pain.

The sweat is then collected and sent for analysis. Getting enough sweat matters. If the sample is too small, the result may not be reliable, so the collection may need to be repeated. This is one reason the test should be carried out by trained staff in a center that follows established procedures.

For many people aged six months or older, a chloride concentration of 60 millimoles per liter or higher is consistent with cystic fibrosis. A result below 30 mmol/L makes the condition less likely. Values from 30 to 59 mmol/L fall into an intermediate range and need further evaluation. For infants younger than six months, the interpretation of lower and intermediate values differs, so clinicians use age-specific guidance.

A high result is important, but it’s not a reason to interpret a number in isolation. Clinicians consider the person’s symptoms, family history, newborn screening results, and, when needed, genetic testing. If a result is unclear, the sweat test may be repeated or followed by other assessments.

What the result can—and can’t—tell you

The sweat chloride test is a key diagnostic tool, but it does not show exactly which CFTR gene changes a person has. Genetic testing can help identify specific variants and add detail to the clinical picture. Some people have clear results on one test and less straightforward findings on another, so the care team may combine evidence rather than rely on a single figure.

Newborn screening is another piece of the process. Many regions screen newborns using a blood sample to look for signs linked to cystic fibrosis. Screening can identify babies who need more assessment, but it isn’t the same as a diagnosis. A positive screening result usually leads to a sweat chloride test and, in some cases, genetic analysis.

There’s a practical reason for this careful approach: screening is designed to flag possible cases, while diagnostic testing aims to establish whether the condition is present. The distinction matters for families, since a screening result can raise questions without providing a final answer.

Different tests answer different questions

Several other laboratory tests may be useful in health care, but they serve different purposes. A Tensilon challenge has historically been associated with evaluating myasthenia gravis, a disorder that affects communication between nerves and muscles. An acid-fast sputum test looks for bacteria such as those that cause tuberculosis. ELISA tests detect particular substances, such as antibodies or antigens, and are used across many areas of medicine.

These tests can all be valuable in the right setting. They simply don’t measure the salt-handling problem linked to cystic fibrosis. The sweat chloride test is especially useful because it checks a direct effect of impaired CFTR function rather than looking for an unrelated infection or immune response.

From diagnosis to daily care

A diagnosis can help explain symptoms that once seemed disconnected—persistent cough, frequent chest infections, poor growth, or digestive trouble. It can also guide care. A cystic fibrosis team may include lung specialists, dietitians, nurses, pharmacists, and other clinicians who focus on different parts of the condition.

Care can include airway-clearance methods to help move mucus from the lungs, medicines to treat infections or reduce inflammation, and nutrition support. Some people are eligible for CFTR modulator medicines, which target the effects of particular gene variants. These treatments have changed what’s possible for many patients, though they don’t suit everyone and don’t replace regular care.

The plan often shifts over time. Lung health, nutrition, treatment response, and daily needs can change, so clinicians keep reviewing the full picture. That ongoing attention may sound like a lot, but it also means care can be tailored to the person rather than built around a single lab value.

One small sample, a wider picture

Sweat chloride testing is a clear example of how basic biology can guide clinical decisions. A small sample reflects a chain of events that begins with a gene, affects a protein, and changes the way cells handle salt and water. That chain helps explain why cystic fibrosis can touch several body systems at once.

A high sweat chloride result can be a major clue, especially when it fits with other findings. Still, the result matters most when interpreted alongside symptoms, age, screening information, and genetic evidence. In that broader context, sweat testing is more than a number on a report—it’s a useful starting point for understanding the condition and shaping care.